Evidence map›Paper›PMID 42536076›Full record

ArticlemSphere2026

An innovative organoid model to screen for bacteria and their metabolites that protect against inflammation-induced colonic barrier disruption.

Nicole Cady, Sophia R Meyer, Kwi Kim, Bernard C Lo, Ngai So, Grace Y Chen, Stephan P Rosshart, Yatrik M Shah, Gabriel Núñez, Jonathan Z Sexton and 1 more

Abstract read
In one paragraph

Article in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nicole CadyDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-3866-1467
Sophia R MeyerDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
Kwi KimDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Bernard C LoDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Ngai SoDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Grace Y ChenDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Stephan P RosshartDepartment of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Yatrik M ShahDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Gabriel NúñezDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Jonathan Z SextonDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-9244-5888
Thomas M SchmidtDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-8209-6055

Funding

Michigan Institute for Clinical and Health Research (MICHR)UM1TR004404 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Julie C Lumeng · 2023 to 2026
$39.8M
Metabolomics CoreP01HL149633 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TEWARI, MUNEESH · 2020 to 2024
$11.1M
Prioritization and Bioactivity Characterization of Novel Bile Acids Produced by the MicrobiomeR01DK140854 · NIDDK · MICHIGAN STATE UNIVERSITY · PI Robert Andrew Quinn · 2024 to 2026
$1.8M
NCATS NIH HHS UM1 TR004404NHLBI NIH HHS P01 HL149633NIDDK NIH HHS R01 DK140854
6 · The paper itself

Abstract

Organoids provide a useful model system to study interactions between gut microbes and the activity of host tissues, including gastrointestinal (GI) barrier function. However, most organoid models have limited capacity to mimic the physiological hypoxia experienced by the colonic epithelium

Indexed as

BacteriaBifidobacterium adolescentisColonGastrointestinal MicrobiomeInflammationIntestinal MucosaOrganoidsAnimalsCoculture TechniquesColitisCytokinesFemaleHumansIntestinal Barrier FunctionMaleMiceCytokinesBifidobacteriumgastrointestinal permeabilityindole-3-lactic acidinflammationphysiological hypoxiaprimary human colonoid

Identifiers

PMID42536076
PMCPMC13508787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.